Aerie Pharmaceuticals
AERI
$15.25
Share price
0.00%
Change (1 day)
83.73%
Change (1 year)
Categories
Aerie Pharmaceuticals (AERI) Fails to deliver data
Key failure to deliver metrics for Aerie Pharmaceuticals:
- Last SEC data release: 2023-10-31
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $0.94 M
Failures to deliver for Aerie Pharmaceuticals (AERI) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Aerie Pharmaceuticals (AERI) - since 2013
Volume in USD (price x number of shares), data since 2013Aerie Pharmaceuticals (AERI) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2022 | $6.87 M | -52.47% |
| 2021 | $14.46 M | -58.63% |
| 2020 | $34.95 M | -21% |
| 2019 | $44.25 M | -0.11% |
| 2018 | $44.29 M | 52.64% |
| 2017 | $29.02 M | -73.67% |
| 2016 | $0.11 B | 60.68% |
| 2015 | $68.59 M | 156.01% |
| 2014 | $26.79 M | 134.11% |
| 2013 | $11.44 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Merck MRK | $6 M | $0.17 B | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $11.5 M | $23.63 M | 🇺🇸 USA |
 Insmed INSM | $2.47 M | $11.43 M | 🇺🇸 USA |